MAPKAP

AcronymDefinition
MAPKAPMitogen Activated Protein Kinase Activated Protein Kinase
References in periodicals archive ?
MMI-0100 is a selective inhibitor of MAPKAP kinase 2 (MK2), a key terminal kinase in the transforming growth factor beta (TGF-U)/p38 signaling pathway.
Based on proprietary technology from Purdue University, the company is advancing a suite of peptide therapeutics that target MAPKAP kinase 2 (MK2), a key terminal kinase in the TGF-beta/p38 pathway, with a high degree of specificity.
MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis.